Litigation Details for Teva Pharmaceuticals International GmbH v. BendaRx USA (D. Del. 2023)
✉ Email this page to a colleague
Teva Pharmaceuticals International GmbH v. BendaRx USA (D. Del. 2023)
| Docket | ⤷ Start Trial | Date Filed | 2023-05-04 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Jennifer L. Hall |
| Jury Demand | None | Referred To | |
| Parties | EAGLE PHARMACEUTICALS, INC. | ||
| Patents | 8,436,190; 8,445,524; 8,609,707; 8,609,863; 8,669,279; 8,791,270; 8,883,836; 8,895,756; 9,533,955; 9,572,887 | ||
| Attorneys | Kassidy Schmitz | ||
| Firms | Shaw Keller LLP, DE | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Teva Pharmaceuticals International GmbH v. BendaRx USA
Details for Teva Pharmaceuticals International GmbH v. BendaRx USA (D. Del. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-05-04 | External link to document | |||
| 2023-05-04 | 50 | Answer to Amended Complaint AND Counterclaim | actions for patent infringement against BendaRx for infringement of U.S. Patent Nos. 8,436,190 (the “’190…INFRINGEMENT BY BENDARX OF U.S. PATENT NO. 8,436,190 UNDER 35 U.S.C. SECTION 271(E)(2) … BY BENDARX OF U.S. PATENT NO. 8,436,190 73. BendaRx incorporates …-infringement and/or invalidity of U.S. Patent Nos. 8,436,190 …the ’190 Patent, ’524 Patent, ’863 Patent, ’279 Patent, ’270 Patent, ’836 Patent, ’756 Patent, ’955 Patent | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
